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Background: While ghrelin was initially related to appetite stimulation and growth hormone secretion, it also has a
neuroprotective effect in neurodegenerative diseases and regulates cognitive function. The cellular basis of those
processes is related to synaptic efficacy and plasticity. Previous studies have shown that ghrelin not only stimulates
synapse formation in cultured cortical neurons and hippocampal slices, but also alters some of the
electrophysiological properties of neurons in the hypothalamus, amygdala and other subcortical areas. However,
direct evidence for ghrelin’s ability to modulate the activity in cortical neurons is not available yet. In this study, we
investigated the effect of acylated ghrelin on the development of the activity level and activity patterns in cortical
neurons, in relation to its effect on synaptogenesis. Additionally, we quantitatively evaluated the expression of the
receptor for acylated ghrelin – growth hormone secretagogue receptor-1a (GHSR-1a) during development.
Results: We performed electrophysiology and immunohistochemistry on dissociated cortical cultures from neonates,
treated chronically with acylated ghrelin. On average 76 ± 4.6% of the cortical neurons expressed GHSR-1a. Synapse
density was found to be much higher in ghrelin treated cultures than in controls across all age groups (1, 2 or 3 weeks).
In all cultures (control and ghrelin treated), network activity gradually increased until it reached a maximum after
approximately 3 weeks, followed by a slight decrease towards a plateau. During early developmental stages
(1–2 weeks), the activity was much higher in ghrelin treated cultures and consequently, they reached the plateau value
almost a week earlier than controls.
Conclusions: Acylated ghrelin leads to earlier network formation and activation in cultured cortical neuronal networks,
the latter being a possibly consequence of accelerated synaptogenesis.
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Ghrelin is a hormone and neuropeptide that was first
identified in the stomach and initially related to the ap-
petite stimulation and growth hormone (GH) secretion
through the activation of the growth hormone secreta-
gogue receptor-1 (GHSR-1) [1]. Ghrelin appears in two
forms: unacilated ghrelin, designated as des-acyl ghrelin
(DAG) and acylated ghrelin (AG), also referred to as
ghrelin [2]. DAG is the dominant form in the blood* Correspondence: stoyanovai@yahoo.co.uk
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article, unless otherwise stated.plasma (90%) [3], and does not bind to the GHSR-1
[2,4]. Acylated ghrelin is produced post-translationally
by octanoylation, a modification which is required for
binding to the GHSR-1 [5].
The receptor has two isoforms: GHSR-1a, which, when
activated by acylated ghrelin or growth hormone secreta-
gogues (GHS), increases the intracellular Ca2+ concentra-
tion, and a splice variant GHSR-1b of unknown functions,
which lacks the Ca2+ signaling capacity [6]. When the
splice variant 1b is co-expressed with GHSR-1a it forms a
heterodimeric association and reduces the signaling cap-
acity of GHSR-1a [7]. GHSR-1b forms heterodimers with
other G-protein-coupled receptors [8], and these hete-
rodimeric receptors bind to peptide hormones other thaned Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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other pathways than Ca2+ signaling [9].
GHSR-1a is prominently expressed in different regions
of the brain. Although the highest concentration of it is
found in the pituitary gland and hypothalamus, consis-
tent with the known role of ghrelin in GH release and
the regulation of body weight and metabolism [10,11],
there is also abundant GHSR-1a expression in other,
extra-hypothalamic areas including the cortex and brain
stem [12-17] suggesting that ghrelin plays a much
broader role [10,18,19]. A recent comparative study on
hippocampal and cortical dissociated neurons showed
that GHSR-1 mRNA expression is higher in the hippo-
campus than in the cortex, and depends on the ma-
turation stage of the cultures [20]. In humans, GHSR-1
mRNA distribution is much more widespread than that
of GHSR-1a, and varies spatially and quantitatively from
that of the receptor [21,22].
Soon after ghrelin’s discovery, ghrelinergic neurons
were detected in different parts of the hypothalamus
[23,24], including an internuclear space not involved in
the metabolism regulation. This suggests a unique cen-
tral role of ghrelin [25], in addition to its role as a
peripheral hormone secreted by gastric endocrine glands
[1]. Later on, ghrelinergic neurons have been detected
also in the cerebral cortex [26-28] indicating that ghrelin
might be involved in higher activities in the central ner-
vous system, like reward, mood, learning and memory
[29-32]. The central role of ghrelin has been further sup-
ported by the findings that ghrelin induces neurogenesis,
as first described in the rat dorsal motor nucleus of the
vagus nerve [33] and the nucleus of the solitary tract
[34] and, subsequently in cultured hippocampal proge-
nitor cells [35], the hippocampus of adult mice [36], and
the rat spinal cord [37,38].
The correlation to cognitive processes was additionally
confirmed by investigations on the effects of ghrelin on
synapse formation and neuronal activity. In ghrelin-
knockout mice ghrelin application not only increased hip-
pocampal dendritic spine formation but also altered some
of the neurophysiological properties such as long-term
potentiation, leading to improved learning and memory
performance [39]. Increased dendritic spine density was
observed in cultured hippocampal slices when treated
with ghrelin [40]. Similarly, accelerated and prolonged
synaptogenesis was observed when cultured cortical neu-
rons were chronically supplemented with ghrelin [41].
Direct application of the hormone in patch-clamp experi-
ments has been shown to increase the electrical activity of
neurons within the hypothalamic arcuate nucleus [25], the
subfornical organ [42], and area postrema [43]. Long-term
exposure to ghrelin in pituitary tumor cell lines also
resulted in an increased frequency of spontaneous action
potentials [44]. Moreover, a very recent study on thelateral amygdala provided evidence that different subpo-
pulations of neurons display diverse responses to ghrelin
[45]. However, direct evidence for acyl-ghrelin’s ability to
modulate the activity in cortical neurons during the for-
mation and development of networks is not available yet.
In this study we investigated the effect of acylated ghrelin
on the activity development of cortical neurons, in
relation to its effect on synaptogenesis and GHSR-1a
expression.Methods
Dissociated cell cultures
Animal experiments were conducted according to
Dutch law (as stated in the “Wet op de dierproeven”)
and approved by the Utrecht Animal Use Committee
(DEC). Wistar rats were bred in the local animal facility.
Cortical cells were isolated from neonatal brains and
plated. To obtain enough cells approximately five pups
(from the same mother) were needed per plating. This
approach ensured a minimum number of donor animals
while obtaining sufficient experimental preparations.
Rat pups were anesthetized with isoflurane and deca-
pitated. The brains were removed and placed in RPMI-
medium (developed at Roswell Park Memorial Institute,
hence the acronym RPMI). After the meninges were re-
moved, the cortices were dissociated and collected in
chemically defined R12 culture medium [46] with tryp-
sin for further promote chemical dissociation. After the
trypsin treatment, 150 μl of soybean trypsin inhibitor
and 125 μl of DNAse I (20.000 units, Life Technology)
were added, followed by mechanical dissociation of the
neurons. The suspension was centrifuged at 1200 rpm
for 5 minutes. For immunostaining, the pellet was
plated on glass cover slips, while for the electro-
physiological experiments, the plating was done in multi
electrode arrays (MEAs) (Multi Channel Systems,
Reutlingen, Germany) at a density of approximately
3000 cells/mm2. The electrodes of the 60 channels pla-
nar TiN/SiN MEA were 30 μm in diameter with an
inter-electrode distance of 200 μm, and were arranged
in a 8 × 8 square array (the four electrodes on the cor-
ners excluded). The impedance of the electrodes was
around 200 kΩ at 1 kHz. The MEAs were pre-coated
with 20 mg/ml poly-ethylene-imine (Fluka, Buchs,
Switzerland) to enhance the glass-cell adhesion. In these
devices, neurons form a “random” network on a global
surface area of 4 mm2 (active surface 1.8 mm2). Cells were
allowed to attach for 2 hours at 37°C and 5% CO2 in air
and kept in R12 medium optimized with 50 ng/ml nerve
growth factor (Invitrogen, Carlsbad, CA). The medium
was serum-free to suppress glial cell proliferation, keeping
their concentration lower than 5% [46]. The medium was
renewed every 2–3 days.
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Cells were kept under standard conditions of 37°C and 5%
CO2 in air either in serum-free R12 medium as controls
(ctrl) or with additional acylated ghrelin (ghr) (ab73131,
Abcam, Cambridge, UK). A wide range of ghrelin con-
centrations ranging from 0.1 nM to 30 μM have been
reported to have an excitatory, synaptogenic, proliferative
and protective effect on hippocampal cells [25,35,39,43,47].
We recently showed that ghrelin accelerates synaptoge-
nesis in a dose dependent manner using concentrations of
0.5, 1, 1.5, and 2 μM [41]. Here, we present the effect of ac-
celerated synaptogenesis on cortical activity.
Immunohistochemistry
We used dissociated cells from eleven plating procedures.
In total 190 cultures were plated on coverslips for synapto-
physin staining. About an equal number of cultures were
used for each condition (ctrl and ghr). After one-, two-,
or three-weeks of incubation, cultures were fixed in 4%
paraformaldehyde in 0.1 M PBS, pH 7.4, and processed
immunocytochemicall using the avidin-biotin-horseradish
peroxidase (ABC) method [48] to detect synaptophysin.
Briefly, hydrogen peroxide (0.3% in absolute methanol
for 30 min) was used to inactivate endogenous peroxi-
dase. Appropriate washes in PBS followed this and subse-
quent treatments. Incubation in primary antibody mouse
anti-synaptophysin IgG (Abcam, Cambridge, UK, dilution
1:1000) lasted for 20 h at room temperature, followed by
2 h in biotinilated donkey anti-mouse IgG (1:500; Jackson
ImmunoResearch, West) and 1 h in ABC (1:500; Vector
Labs, Burlingame, CA, USA). Following rinsing, peroxidase
activity was visualized using the 2.4% SG substrate kit for
peroxidase (Vector) in PBS for 5 min, at room temperature.
Finally, the cultures were dehydrated in a graded series of
alcohols, cleared in xylene, and coverslipped with Entellan
(Merck, Darmstadt, Germany). Negative controls included
incubation after antigen-antibody preabsorption with the
native antigen, at 4°C for 24 h, or replacement of the pri-
mary antibody with non-immune serum at the same con-
centration. The same procedure was applied for detection
of GHSR-1a expression after one day, and one, two, three
and four weeks in vitro, using rabbit anti-ghrelin receptor
type 1a (Chemicon/Millipor, Billerica, MA, USA, dilution
1:100) as a primary antibody, biotinilated goat anti-rabbit
IgG (1:500; Jackson ImmunoResearch, West) as a secon-
dary antibody, and ABC complex (1:500; Vector Labs,
Burlingame, CA, USA). Negative controls included incuba-
tion after antigen-antibody preabsorption with the native
antigen, at 4°C for 24 h, or replacement of the primary anti-
body with non-immune serum at the same concentration.
Data analysis and photomicrograph production
After staining, micrographs were generated at 40x and
60x using a Nikon DS-Fi1 digital camera linked to aNikon Eclipse 50i microscope. All digital images were
matched for brightness in Adobe Photoshop 7.0. For
quantitative analysis of synaptic marker expression, we
counted the number of granules of the reaction pro-
duct after synaptophysin staining. We used Nikon NIS-
Elements software and obtained estimates of the mean
densities and standard deviations. First, we qualitatively
graded the overall density of immunostaining of neurons
into three categories: high, medium and low, following the
procedure described by Ljungdahl et al. [49]. Then, we
calculated the granule density under high magnification at
two different neurons from each category, obtained from
10 to 24 analyzed specimens per condition (ctrl or ghr) at
age 1, 2 or 3 weeks. Because the largest differences in syn-
aptic expression were detected during the first two weeks
of incubation, we counted the synaptophysin expression
during three weeks of incubation. To avoid bias due to
differences in the cell density across the cultures, we re-
stricted this analysis to the area of the perikarya and the
initial part of the arbotizations. Analysis of neurons from
all three categories yielded relatively high standard de-
viations in the average density per condition, per age.
Two-way ANOVA was applied to assess the statistical sig-
nificance of the differences in density. Known sources of
variation were the treatment applied to the cultures (con-
trols vs. ghrelin treated) and the culture age. All data were
presented as mean ± standard error of the mean (SEM)
unless stated otherwise. A p-value smaller than 0.05 was
considered statistically significant.
Cell counts for GHSR-1a expression were performed
on five randomly chosen cultures per age group. The
fraction of GHSR-1a positive neurons was calculated per
each count. All data were presented as the mean ± S.D.
(standard deviation).
Electrophysiology
Neurons were obtained from eight different plating
preparations and were cultured for a period of at least
four weeks in R12 supplemented with acylated ghrelin
at a concentration 0.5 μM (n = 3), 1 μM (n = 3) or 2 μM
(n = 5). Neuronal activity was recorded for at least one
hour on at least eight different days in vitro (DIV). For
controls, we used seven sister cultures incubated in R12.
Combining the data of all experiments, we plotted the
mean firing rate as a function of age. All data was
grouped into bins with a bin size of five days of age.
With this approach, the large differences between the
activity levels of individual cultures yielded relatively
large error bars.
In addition, we normalized the individual curves to
their mean value before averaging across experiments.
This procedure yielded curves that showed the relative
development of activity, emphasizing periods of rela-
tively fast or slow development. T-tests per age group,
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cance of the differences between network activity in con-
trols and ghrelin treated cultures at different age groups.
P-values <0.05 were considered as significant.
Results
Specificity of the immunostaining
Specificity of the immunoreaction was tested with two
methods: Preincubation of the antiserums with the na-
tive proteins totally abolished the immunoreaction. Also,
no labeling was observed when the antiserums were
replaced by non-immune serum at the same concentra-
tion. The immunoreactivity was readily discernible at
the light microscopic level by the presence of a dark-
gray immunoreactive product. Neuronal structures were
considered to be immunopositive when their staining
was clearly stronger than that in the background.
GHSR-1a immunoreactivity
Immunocytochemical labeling revealed that 76.3 ± 5.1% of
all neurons after one day of culturing expressed GHSR-1a,
unevenly distributed on the neurons. Both bipolar and
multipolar neurons with several major neurites emerging
from a stellate-shaped soma were GHSR-1a-immunoreac-
tive (IR). Similar fractions of neurons expressing GHSR-1a
were observed in cultures after one to four weeks (82 ±
5%, 78.2 ± 7.4%, 73.1 ± 7.4%, and 70.3 ± 10.9%, respec-
tively). On average, 76 ± 4.6% of the neurons of all age
groups exhibited GHSR-1a.
Chronic effect of acylated ghrelin on electrical network
activity and synaptophysin expression
Immunostaining for synaptophysin revealed that chronic
treatment of the cultures with varying concentrations of
acylated ghrelin (0.5, 1, and 2 μM) led to considerable
changes in synapse development. Figure 1 shows a typical
example illustrating the synapse density in cultures chro-
nically treated with 1 μM acylated ghrelin. A week after
plating in ghrelin-supplemented medium (Figure 1.1A),
neurons showed some expression of synaptophysin (0.54 ±
0.13 granules/μm2), while in control (ctrl) (Figure 1.1B) it
was less pronounced (0.34 ± 0.13 granules/μm2). Granules
of reaction product were located mainly on the somata,
but sparse immunoreactivity was also observed along the
neurites. After two weeks in vitro (WIV), synaptophysin
appearance was detected in all cultures (ghr and ctrl), but
was far more abundant in ghr (0.83 ± 0.42 granules/μm2)
(Figure 1.1A) cultures than in ctlr cultures (0.49 ± 0.14
granules/μm2) (Figure 1.1B). Both the perikarya and neu-
rites were synaptophysin immunopositive. After three
weeks of incubation we found a substantially higher
expression of synaptophysin in ghr treated neurons
(0.84 ± 0.16 granules/μm2) (Figure 1.3A), compared to ctrl
(0.66 ± 0.22 granules/μm2) (Figure 1.3B). Two-way ANOVAshowed that the synapse density significantly depended on
age (p = 0.0005) and conditioning (ghr or ctrl) (p = 0.0043),
but not on the interaction of these factors (p > 0.7439). The
densities were always higher in ghr than ctrl. These results
are illustrated in Figure 2.
Experimental data for neuronal activity were obtained
from eleven ghrelin treated cultures from eight different
preparations. These cultures were monitored for at least
four weeks, with some of them even up to 3 months.
Activity from these cultures was recorded on 12 ± 3 (SD)
different days. Seven non-treated sister cultures were
used as controls and all recorded for at least one hour
on 10 ± 3 (SD) different days. All cultures exhibited
strongly varying patterns of spontaneous activity during
their temporal maturation. Initially, there was no activity
but when connectivity increased some neurons became
sporadically active. As network formation progressed,
most neurons became active and firing patterns usually
displayed network burst. When cortical networks were
incubated under control conditions (Figure 3A), at 6
DIV usually only random spikes were generated at a few
electrodes with no clear evidence of collective bursts.
Ghrelin conditioning of the medium at all concen-
trations led to an earlier onset of network activity and
development of bursting patterns. In general, when neu-
rons are dissociated and cultured they show activity pat-
terns which include periods of highly synchronized
firing, behavior considered somewhat epileptic. However,
we did not observe more pronounced bursting in ghrelin
treated cultures except at younger culture ages, at the
onset of bursting. At a young age, the activity of ghr cul-
tures was substantially higher than that of the controls.
In fact, in the first 10 days, the average activity was 2.3
times higher in ghrelin treated cultures. The activity pat-
tern we observed at 6 DIV in ghr cultures (Figure 3B)
did not normally appear before the end of the second
week (11–12 DIV) in ctrl cultures. The ghr cultures ex-
hibited some activity as early as 3–4 DIV (Figure 4A).
Even after 3 months in vitro they still had high firing
rate (Figure 4B).
We compared the development of network activity in
cultures treated with 0.5 μM (n = 3), 1 μM (n = 3), or
2 μM (n = 5) acylated ghrelin. At all concentrations, we
saw increasing activity up to a maximum after 15–20
DIV, followed by a slight decrease to a plateau that
lasted at least until 25–30 DIV. The absolute values of
firing rates within groups showed quite large standard
deviations, and differences between different concen-
trations were not significant at all ages (p ≥ 0.2; 2-tailed
t-test, unequal variances. Mean p value of 0.52). Two
way ANOVA showed that network activity significantly
depended on age (p < 0.05), but not on concentration.
To diminish the influence of the differences between the
absolute firing rate of the individual cultures, and to
Figure 2 Quantified synaptophysin expression during culture
development. Synaptophysin is quantified from images as in
Figure 1 at different ages under control (ctrl) conditions and after
chronic treatment with ghrelin (ghr). Expression was significantly
higher in ghrelin treated cultures than in control (p < 0.001). Error
bars indicate SEM.
Figure 1 Light microscopy of synaptophysin expression. (1) One-week-, (2) two-weeks-, and (3) three-weeks-old neuronal cultures immunostained
for synaptophysin after (A) 1 μM acylated ghrelin ghrelin pretreatment and (B) control incubation. The reaction product appeared as dark-gray dots.
Arrows point at examples of neuronal perikarya with high density of staining. Double arrows point at neurites with synaptophysin expression. Scale
bars: 20 μm.
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vidual experiments to their mean value. Still, differences
between different concentrations were not significant at
all ages (p > 0.24; 2-tailed t-test, unequal variances. Mean
p of 0.62). To gain statistical power, we pooled the data
from all ghrelin treated cultures. Figure 5A shows the
mean network activity in controls and ghrelin treated cul-
tures at different age groups. The activity significantly
depended on age (two-way ANOVA, p < 0.02) and was
significantly higher in ghrelin treated cultures (two-way
ANOVA, p < 0.03). Due to the large spread within groups,
most differences (ctrl vs. ghr) per age group were not
significant, except the difference at 5–10 DIV when
ghr cultures were on average three times more active
(p < 0.04; 2-tailed t-test, unequal variances). Then, individ-
ual curves were normalized to their mean values to
emphasize periods of fast or slow development. Figure 5B
shows the development of normalized network activity in
cultures treated with ghrelin and control cultures. In gene-
ral, in ghr and ctrl cultures the activity level initially
Figure 3 Effect of ghrelin on network activity. Raster plots of the neuronal activity recorded over 20 minutes (x-axis) in cultures incubated
with ghrelin and controls at age DIV 6. The top rows of the panels depict only the electrodes in contact with active neurons (electrode numbers
are on y-axis). Each tick represents a recorded action potential. The bottom rows of the two panels represent the summed network activity.
(A) Network activity in a sister culture under control conditions, 47 spikes recorded in 1 minute. (B) Network activity in a culture chronically
treated with ghrelin, 3740 spikes recorded in 1 minute.
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then stabilized at a slightly lower plateau. In ghr cultures,
the mean firing rate increased much faster in young cul-
tures up to approximately 2 weeks and first reached their
plateau value before day 10, which was considerably ear-
lier than the controls (around 15 DIV). The activity bet-
ween 5 and 10 DIV was significantly higher in ghr than
ctrl (p < 0.01; 2-tailed t-test, unequal variances).
Discussion
In vitro cultured networks can be easily manipulated
while maintaining many of the cortical cellular proper-
ties [50]. Therefore, they provide a suitable model to get
a first impression of the possible effect of acylated
ghrelin in vivo. For proper interpretation of these effects,it is important to mention that the paradigm for the nat-
ural establishment of neural circuits is known to proceed
in three-stages: 1) early activity-independent wiring to
produce a rough map characterized by excessive synaptic
connections; 2) subsequent, use-dependent pruning to
eliminate inappropriate connections and reinforce the
functioning synapses [51]; and 3) succeeding homeostatic
balance with reciprocal influence between the develop-
ment of neuronal connectivity and intrinsic bioelectrical
network activity [52].
At the end of the first phase, when neurons form exten-
sive interconnections, they create functional networks,
which exhibit frequent spontaneous action potentials
discharges [53]. The frequency of these bursts of activity
usually emerges towards the end of the first week in vitro
Figure 4 Extensive activities recording from ghr culture. (A) Raster plot of the neuronal activity recorded from ghrelin treated culture at 4
DIV (368 spikes per minute). (B) Raster plot of the activity recorded for 20 min from ghr culture at age 88 DIV. The activity level is still high
(6652 spikes per minute).
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From then on the activity patterns exhibit periods of
elevated firing rates with ongoing repetition of distinctive
firing patterns, including network bursts, which evolve
gradually in the end of the third week, followed by a
drastic shortening of the network bursts after about four
weeks of culturing. The burst intensity profiles become
quite stable from about 30 days not only in cortical cul-
tures [56,57], but also during the early postnatal life, as
shown in lightly anesthetized rat neocortex in vivo [58,59].
The pattern of neuronal activity appears to be strongly
dependent upon network interconnectivity [60].
Recently, ghrelin expression was found in dissociated
cortical neurons with a clear conditioning- and time-related pattern in the transmitter appearance: very early
ghrelin expression at a high level, followed by matu-
rational decrease in the next two weeks of culturing
[27,28]. This qualitatively mimics the in vivo time course
of development of networks, the survival of which re-
quires synapse consolidation and activation during the
first two weeks [61,62]. In cerebral cortex cultures, the
synapse density increases in parallel to the spontaneous
activity development from 7 to 21 DIV [63]. In the initial
stages of network development, connectivity is sparse and
consequently activity is low. Still, neurons need a certain
amount of activity to survive [64]. The ghrelinergic system
might contribute to maintaining a healthy level of activity,
possibly through accelerated synaptogenesis. Indeed, our
Figure 5 Summary of firing rate development. Development of
the activity levels in ghrelin treated cultures (ghr, n = 11) and controls
(ctrl, n = 7). (A) The average activity levels of both groups at different
culture ages, up to 30 days in vitro (DIV). Error bars indicate the SEM
and reflect differences between cultures. *indicates a significant
difference (p < 0.04; 2-tailed t-test, unequal variances). The absolute
activity levels differed substantially between cultures within either
group. To emphasize the rate of development at different ages, we
normalized the activity development of all individual experiments to a
mean value of 1 before averaging across cultures. (B) The mean
normalized activity levels at different ages. Error bars indicate the SEM.
*indicates a significant difference (p < 0.01; 2-tailed t-test, unequal
variances).
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synapses in acylated ghrelin treated cultures than in
control experiments. Because we used acylated ghrelin,
which has been shown to bind only to GHSR-1a [65],
and most cortical neurons did express GHSR-1a, the
synaptogenic effect of ghrelin is most likely mediated
by GHSR-1a. Acylated ghrelin increases Ca+2 influx
[44,66]. E.g. the inositol phosphate signaling pathway,
inducing intracellular calcium mobilization [44,66,67]
through phospholipase C activation, is specifically as-
sociated with the GHSR-1a ligand-dependent activity
[68,69]. Therefore, we hypothesize that the underlying
mechanism for this synaptogenic effect of ghrelin may
involve synaptic gene nuclear factors expression, many
of which are calcium-dependent [70].
Ghrelin conditioning of the culturing medium resulted
in earlier establishment of synaptic contacts and emergingspontaneous neuronal activity as early as 3DIV, which rap-
idly and continuously increased till 17–18 DIV, followed
by a decline till 21–23 DIV. The first activity appeared
much earlier in ghrelin treated cultures than in the con-
trols and reached a ”mature” type (i.e. including network
bursts) much earlier. In contrast, spontaneous activity of
non-treated cultures usually begins toward the end of the
first week in vitro and is initially asynchronous [54]. Thus,
chronic ghrelin application had a strong stimulating effect
on network activity in developing cultured cells, and to
our knowledge, this study demonstrates it for the first
time.
Ghrelin probably excites excitatory neurons, as well as
inhibitory ones, and therefore, the total activity would
increase or decrease, depending on the balance between
excitation and inhibition. Approximately 20-25% of the
cortical neurons are inhibitory GABAergic [71,72], and
they usually express a developmental shift in their ac-
tions: at young age, GABA depolarizes postsynaptic neu-
rons instead of hyperpolarizing them. This effect takes
place during the first 8–9 postnatal days (P) or DIV
and does not last beyond day 12 [73,74]. Ghrelin may
directly excite those interneurons, leading to increased
network activity in the first two weeks and increased in-
hibition after the end of the second week [75].
On the other hand, the firing rate of ghr cultures after
three weeks in vitro, which is beyond this switch of
GABAergic neurons, is still much higher than in ctrl
cultures. This suggests that the predominant effect of acyl-
ated ghrelin involves the formation of excitatory synapses,
thus causing augmented network activity. To validate this,
it would be beneficial to determine the effect of ghrelin on
postsynaptic density protein 95 (PSD-95) expression,
which anchors and organizes postsynaptic neurotrans-
mitter receptors [76] and is known to be expressed only at
excitatory synapses [77,78]. However, this was beyond the
scope of the current study.
The decline in firing rate observed in both ghr and ctrl
cultures after three weeks, could be ascribed to the
phenomenon of synaptic pruning, which is part of the nat-
ural formation of neural circuits [51], initiated by signaling
through NMDA-receptors [79]. The functional signifi-
cance of synapse elimination during maturation probably
involves adjustment of the excitatory/inhibitory balance
on individual neurons and within networks. The main
argument in support of this assumption is the specificity
of the loss: excitatory synapses are selectively degene-
rated whereas inhibitory synapses are spared [80,81]. This
excitatory/inhibitory balance is important for cortical net-
works to function properly [82,83] and the maintenance
of this balance requires a form of homeostatic plasticity.
In adult cortical networks, it is dynamically regulated to
avoid runaway excitation which will bring the network
into an epileptic-like state or quiescence, in response to
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considerations, one would expect the higher activity in
cultures chronically treated with ghrelin to slow down ex-
citatory synaptogenesis. Still, in acylated ghrelin treated
cultures, we found an increased synaptogenesis and ele-
vated firing levels, which suggests that the synaptogenic
effect of ghrelin exceeded the homeostatic effect.
The stimulating effect of ghrelin during the initial stages
of network development suggests that ghrelin may provide
an additional mechanism to maintain healthy activity
levels when activity would otherwise be too low, as may
occur, for instance, after stroke. In developmental periods
of low activity, synapse formation and inter-neuronal
communication are both very important for brain de-
velopment and functioning. Our results suggest that acyl-
ated ghrelin may support those processes, at least in our
in vitro preparation. This is in agreement with previous
studies reporting anti-appoptotic and neuroprotective ef-
fects of ghrelin [19,86,87]. It was also supported by our
own findings during a difficult culturing period, when
most cultures died early. Although most of those cultures
became active, the duration of their activity was too short
to be included in this study. Still, ghrelin treated cultures
survived much longer than control cultures, which were
active on average for 8 ± 7 days, while ghrelin treated cul-
tures were active for 18 ± 6 days.
The ghrelin concentrations used in this study are rela-
tively high, compared to physiological levels, which might
induce nonspecific effects. However, it has been recently
reported that in vitro at 1 μM concentration, 50% of the
neurons of area postrema exhibit a response, 48% of the
neurons react at 100 nM, 38.7% at 10 nM, and only 20%
at 1 nM ghrelin [43].
Though an earlier study showed that concentration did
significantly affect synapse densities [41], the results from
the present experiments indicate no significant effect of
different ghrelin concentrations on network activity. It is
possible that activity development also depended on con-
centration, but our sample sizes were not large enough to
detect that. However, this study did not focus on a quan-
titative description of dose dependent activity changes,
but aimed to qualitatively describe the effect of acylated
ghrelin on network activity.
Conclusions
At all three concentrations, we observed similar dif-
ferences from control activity development, supporting
the conclusion that chronic acylated ghrelin application
has a stimulatory effect on synaptogenesis, leads to ear-
lier onset of activity and generation of “mature” network
activity patterns, and in general to higher activity levels.
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